key: cord-0968489-5sguz8wt authors: Alareedh, Mohammed; Nafakhi, Hussein; Shaghee, Foaad; Nafakhi, Ahmed title: Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia date: 2021-01-19 journal: Ann Noninvasive Electrocardiol DOI: 10.1111/anec.12824 sha: 8b187e3eb1cc4fc7db01caa1ef513c1b92838363 doc_id: 968489 cord_uid: 5sguz8wt BACKGROUND: Little is known about the role of ECG markers of increased risk of sudden cardiac death during the acute period of coronavirus disease 2019 ( COVID‐19) pneumonia. OBJECTIVES: To evaluate ECG markers of sudden cardiac death on admission, including the index of cardiac electrophysiological balance (iCEB) (QTc/QRS) and transmural dispersion of repolarization (TDR) (T from peak to end (Tp‐e) interval and Tp‐e/QTc), in patients with COVID‐19 pneumonia. PATIENTS AND METHODS: This cross‐sectional study included 63 patients with newly diagnosed COVID‐19 pneumonia who presented to the outpatient clinic or admitted to the respiratory care unit between August 20 and September 15, 2020. Forty‐six persons matched for sex and age were selected from data collected before COVID‐19 pandemic. RESULTS: QRS and QTc showed a significant prolongation in patients with COVID‐19 pneumonia compared to the controls (87 vs. 78, p < .00, and 429 versus. 400, p < .00, respectively). After categorization of patients with COVID‐19 pneumonia into 3 groups according to the severity of pneumonia as mild‐moderate, severe, and critical groups, a decreased values of QRS were observed in the critical COVID‐19 pneumonia group compared to severe and mild‐moderate COVID‐19 pneumonia groups (p = .04) while increased values of QTc and iCEB(QTc/QRS) were noted in critical COVID‐19 pneumonia group compared to other 2 groups(p < .00). CONCLUSIONS: Patients with COVID‐19 pneumonia showed significant changes in repolarization and conduction parameters compared to controls. Patients with mild to severe COVID‐19 pneumonia may be at low risk for torsades de pointes development. Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which predominantly affects the lung and may progress to pneumonia, respiratory failure, and even death (Kwenandar et al., 2020; McCullough etal.,2020; Xiongetal.,2020) . Cardiac involvement and cardiovascular dysfunction are possible complicationsassociatedwithCOVID-19infection.Datafromprevious outbreaks and recent case reports have demonstrated the ad-verseeffectsofCOVID-19ontheheart,includingmyocarditis,heart failure, heart block, arrhythmias, and sudden cardiac death (Xiong etal.,2020; Yenerçağetal.,2020) . A common cardiac manifestation in patients with COVID-19 infection is disturbances of cardiac rhythm. In a cohort study of 137 hospitalized patients with COVID-19 infection, 75 of enrolled patients complained of palpitation as a presenting symptom (Bacharova, 2019; Bertini et al., 2020) Furthermore, arrhythmias is one of the most known causes of death in critically ill patients. A higher rate of arrhythmic events was reported in patients with COVID-19 infection particularly in those admitted to intensive care unit where the prevalence rate was double in comparison with non-intensive care unit patients (16(44.4%) vs. 7(6.9%), p < .00; Wangetal.,2020)However,thespecifictypeandpotentialunderlying mechanisms are not defined and remained a challenging issue in clinicalpractice(Vlachakisetal.,2020). and markers in COVID-19 infection is still sparse and not fully defined (Angeli et al., 2020) Also, little is known about the role of ECGabnormalitiesandmarkersofincreasedriskofadversecardiac eventsparticularlyduringtheacuteperiodofCOVID-19pneumonia (Angelietal.,2020). Recently, several novel electrocardiographic markers, including transmuraldispersionofrepolarization(TDR)ofleftventricle,measured by T peak to end interval (Tp-e) and Tp-e/QTc, and index of cardiacelectrophysiologicalbalance(iCEB),measuredbyQTc/QRS, are proposed to be associated with increased risk of malignant arrhythmias and sudden cardiac death in several cardiovascular diseases (Yenerçağetal.,2020; Al-Mosawietal.,2018; Nafakhietal., 2018; Mandala&Di,2017) . ThepresentstudyaimedtoassesstheECGmarkersofincreased risk of malignant arrhythmias and sudden cardiac death on admission, including iCEB (QTc/QRS) and TDR (Tp-e interval and Tp-e/ QTc),inpatientswithCOVID-19pneumonia. This was observational cross-sectional study included 63 patients withnewlydiagnosedCOVID-19pneumoniawhopresentedtothe outpatientclinicoradmittedtotherespiratorycareunit(RCU)atAl-Amal(theHope)specializedhospitalforcommunicablediseasesin Al-NajafgovernoratefromAugust20,2020,toSeptember15,2020. All patients were presented with features consistent with COVID-19 pneumonia based on clinical symptoms and radiological findings (CXR or computerized tomography (CT) examination of the lung). The diagnosis of COVID-19 was confirmed by polymerase chain reaction (PCR) nasopharyngeal swab. Patients with chronic kidney disease,anti-arrhythmicmedications,pacemakerimplantation,and atrialfibrillationanduninterpretableECGpaperwerenotincluded in the present study. The baseline clinical characteristics for each patient were re-cordedatthetimeofoutpatientclinicvisitorRCUadmission,includingage,sex,comorbidities,bodymassindex(BMI),anddrughistory. The control group consisted of 46 age-and sex-matched persons who proved to have normal coronary arteries according to CT coronaryangiographyexamination,havingnolungdisease,valvularor myocardial diseases. Controls were selected from our previous work collected before the COVID-19 pandemic Nafakhi et al., 2018) . Approval of this study was provided by our medicine college board. The12-leadECGswereobtainedforallpatientsatthetimeofoutpa- StatisticalanalysiswasperformedusingSPSSver.23.0(SPSSInc.,). Clinical data of the patients and ECG markers were expressed as mean ± standard deviation for continuous variables or as numbers withpercentagesforcategoricaldata.Student'st-test was used to assess the distribution of clinical patients' characteristics and ECG markers between the COVID-19 pneumonia group and controls. amongCOVID-19pneumoniagroupswereevaluatedusingone-way ANOVAtest.p-value of <.05waschosenforstatisticalsignificance. According to the severity of COVID-19 pneumonia, patients were assigned into 3 groups as mild-moderate COVID-19 pneumonia group consisted of 48 (76%) patients not requiring hospital admission and treated at home with lung injury <50%onCTexamination, The finding of increased QRS duration and QTc interval in patients with COVID-19 pneumonia is consistent with other studies (Antzelevitch,2005; Bertinietal.,2020; Çınaretal.,1992) . A multi-center analysis of 431 hospitalized COVID-19 patients reportedthatQTcprolongationwasthemostfrequentfinding(38%) which can be attributed to critical illness and hypoxemia. Also, a significant prolongation in the QRS interval was found in 19% of enrolled patients, particularly among elderly patients, which can be attributed to right ventricular dysfunction in the context of respiratory failure even before starting drug therapy for COVID-19 infection (Bertini et al., 2020) . Other researchers also found that (Çınar et al., 1992; Yenerçağetal.,2020)However,lackofenrollmentofpatientswith COVID-19 pneumonia or lung involvement and controls before COVID-19infectionwerethemainlimitationsoftheabove2studies. It has been suggested that ECG markers may have a different predictive impact among different diseases (Mandala & Di, 2017) . The prolongation of QTc interval may not increase the TDR and group should be taken with caution because of a very small number of enrolledpatientswithcriticalstatus(5(8%))andhigherprevalenceof male and elderly patients in the critical group than in other pneumonia groups,whichmayhaveledtoaselectionbias. Alargesamplewithafollow-upstudyisrequiredtoconfirmthe results of the present study. PatientswithCOVID-19pneumoniashowed significant changes in repolarization and conduction parameters compared to controls. Patientswithmild-moderateandsevereCOVID-19pneumoniamay beatlowriskforthedevelopmentoftorsadesdepointes,butthe risk of classical ventricular tachycardia/fibrillation is still present inmild-moderateandsevereCOVID-19pneumoniagroups,asevi-dentbydecreasedTDRandmarkedvariationiniCEBvaluesamong COVID-19pneumoniagroups. The authors declare that they have no conflict of interest. The data that support the findings of this study are available from thecorrespondingauthoruponreasonablerequest. Hussein Nafakhi https://orcid.org/0000-0002-0238-0460 ECGmarkersofarrythmogenicriskrelationshipswith pericardial fat volume and BMI in patients with coronary atherosclerosis Electrocardiographic features of patients with COVID-19 pneumonia 19: A systematic review Roleoftransmuraldispersionofrepolarizationin the genesis of drug-induced torsades de pointes Missinglinkbetweenmolecularaspectsofventric-ulararrhythmiasandQRScomplexmorphologyinleftventricularhypertrophy Electrocardiographic features of 431 consecutive, critically illCOVID-19patients:Aninsightintothemechanismsofcardiacinvolvement COVID-19 and acute myocarditis: Current literature review and diagnostic challenges Coronavirusdisease2019andcar-diovascular system: Anarrative review. IJC Heart & Vasculature Clinical characteristics of novel coronavirus cases in tertiary hospitals in HubeiProvince ECGparametersformalignantventricular arrhythmias:Acomprehensivereview Electrocardiographic findings in Coronavirus Disease-19: Insights on mortality and underlying myocardial processes RiskofQTIntervalprolongationassociated withuseofhydroxychloroquinewithorwithoutconcomitantazithromycin among hospitalized patients testing positive for coronavirus disease2019(COVID-19) InterpretationofarrhythmogeniceffectsofCOVID-19dis-easethroughECG Evaluationofindexofcardio-electrophysiologicalbalance(iCEB)asaNewbiomarkerfortheidentification of patients at increased arrhythmic risk Effect of Chloroquine, Hydroxychloroquine, and AzithromycinontheCorrectedQTIntervalinPatientsWithSARS-CoV-2Infection Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death Current data on the cardiovascular effects of COVID-19 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Coronavirusesandthecardiovascularsystem:Acuteandlong-term implications Evaluationof electrocardiographic ventricular repolarization variables in patients withnewlydiagnosedCOVID-19 Indexofcardiacelectrophysiologicalbalanceandtransmuraldispersion of the repolarization index relationships with pericardial fat volume and coronary calcification